- freely available
Advances in Lipid Nanoparticles for siRNA Delivery
AbstractTechnological advances in both siRNA (small interfering RNA) and whole genome sequencing have demonstrated great potential in translating genetic information into siRNA-based drugs to halt the synthesis of most disease-causing proteins. Despite its powerful promises as a drug, siRNA requires a sophisticated delivery vehicle because of its rapid degradation in the circulation, inefficient accumulation in target tissues and inability to cross cell membranes to access the cytoplasm where it functions. Lipid nanoparticle (LNP) containing ionizable amino lipids is the leading delivery technology for siRNA, with five products in clinical trials and more in the pipeline. Here, we focus on the technological advances behind these potent systems for siRNA-mediated gene silencing.
Share & Cite This Article
Tam, Y.Y.C.; Chen, S.; Cullis, P.R. Advances in Lipid Nanoparticles for siRNA Delivery. Pharmaceutics 2013, 5, 498-507.View more citation formats
Tam YYC, Chen S, Cullis PR. Advances in Lipid Nanoparticles for siRNA Delivery. Pharmaceutics. 2013; 5(3):498-507.Chicago/Turabian Style
Tam, Yuen Y.C.; Chen, Sam; Cullis, Pieter R. 2013. "Advances in Lipid Nanoparticles for siRNA Delivery." Pharmaceutics 5, no. 3: 498-507.
Notes: Multiple requests from the same IP address are counted as one view.